Navigation Links
Experimental Vaccine Shields Monkeys Against Ebola
Date:5/21/2010

U.S. team develops shot that protects against 3 strains

FRIDAY, May 21 (HealthDay News) -- Researchers say they've created a vaccine that protects monkeys against three strains of the Ebola virus, a notoriously lethal germ that became widely known to the public thanks to the 1990s non-fiction bestseller The Hot Zone.

The fearsome virus, which is native to Africa, kills up to 90 percent of its victims and is marked by a high fever and massive internal bleeding. Researchers have not yet found a way to treat the virus or to prevent its spread through vaccines.

Researchers led by Nancy J. Sullivan of the Vaccine Research Center at the U.S. National Institute of Allergy and Infectious Diseases developed an experimental vaccine and tested it on four cynomolgus macaque monkeys. They showed no signs of illness after being exposed to a strain of the disease, while all of four unvaccinated monkeys became sick after being exposed, and three of them died.

The researchers are now trying to figure out why the vaccines worked so well. "Once we identify those critical aspects, we can design future vaccines to better elicit that desired immune cell-based activity and perhaps make a single vaccine that protects against all Ebola virus species," Sullivan said in a news release.

The new research "shows that it is possible to generate immunity to newly identified species of Ebola virus with a vaccine originally designed to protect against a different species," added Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, in a press release. "This finding will guide future vaccine design and may open an avenue for developing a single vaccine that works against both known and emerging Ebola virus species."

More information

For more on research on Ebola fever and other acute viral diseases, try the National Institute of Allergy and Infectious Diseases .



-- Randy Dotinga



SOURCE: National Institute of Allergy and Infectious Diseases, May 20, 2010, new release.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Experimental stem cell treatment arrests acute lung injury in mice, study shows
2. Experimental Drug Offers Hope for Cystic Fibrosis Patients
3. IOM report on national vaccine plan
4. Centegra Expands H1N1 Vaccines to General Public
5. UM School of Medicine scientists find new malaria vaccine is safe and protective in children
6. FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries
7. Free H1N1 Vaccines Available at Concentra Urgent Care
8. PA Department of Health Continues to Offer Free H1N1 Flu Vaccine on Saturdays at 60 State Health Centers
9. PATH commends the Gates Foundation for their new commitment to fund vaccine innovation and delivery
10. Virus-like particle vaccine protects monkeys from chikungunya virus
11. Rotavirus Vaccine Could Save Millions of Children Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: